Trial-based Economic Evaluation of a Mobile Health Intervention for Individuals With Chronic Non-specific Low Back Pain
Launched by UNIVERSITY OF BRASILIA · Oct 18, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new mobile health program designed to help people with chronic low back pain. The goal is to see if this personalized mobile approach is more effective and cost-efficient than traditional exercise therapy. Participants will use a smartphone-based program that provides guidance and support to manage their pain and improve their overall well-being.
To be eligible for the study, you need to be between 18 and 59 years old and have experienced low back pain for at least 12 weeks, with a pain level of 4 or higher on a scale from 0 to 10. You should also have a smartphone with internet access and not have received physiotherapy for your back pain in the last six months. However, if you have had certain medical issues, such as spinal surgery, serious injuries, or specific conditions like fibromyalgia, you won't be able to participate. If you join the study, you'll be guided through the mobile health program and will have the chance to help researchers understand how effective this new method is for managing low back pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged between 18 and 59 years;
- • Self-reported low back pain for more than 12 consecutive weeks prior to the study, with pain intensity ≥4 in the numerical rating scale (NRS);
- • Not having participated in physiotherapy sessions for treatment of low back pain for at least 6 months prior to the start of the study;
- • Having a smartphone with internet access;
- • Self-management activation classified as Level 2 or higher (i.e., classifications of low, medium and high knowledge about self-management), according to the Patient Activation Measure (PAM) questionnaire.
- Exclusion Criteria:
- • History of spinal trauma or fracture;
- • Diagnosis of spinal osteoarthritis, fibromyalgia, or rheumatic diseases; 3) Referred pain (from viscera, appendicitis, abdominal and pelvic pain);
- • Previous spinal surgery;
- • Presence of red flags, signs and/or symptoms of neurological impairment and/or pain radiating below the knee;
- • Pregnancy.
About University Of Brasilia
The University of Brasília is a prestigious academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring the highest standards of ethical conduct and scientific rigor in its trials. With a commitment to addressing pressing health challenges and contributing to the global body of medical knowledge, the University of Brasília plays a pivotal role in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ceilândia, Df, Brazil
Campo Grande, Ms, Brazil
Patients applied
Trial Officials
Rodrigo L Carregaro, PhD
Study Director
University of Brasilia
Fernanda Pasinato, PhD
Study Chair
University of Brasilia
Thomaz N Burke, PhD
Study Chair
Federal University of Mato Grosso
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported